Quintiles Transnational Holdings Inc (Q) : Corsair Capital Management added new position in Quintiles Transnational Holdings Inc during the most recent quarter end. The investment management firm now holds 208,125 shares of Quintiles Transnational Holdings Inc which is valued at $15,973,594 , the company said in a statement filed on Aug 8, 2016 with the SEC.Quintiles Transnational Holdings Inc makes up approximately 2.37% of Corsair Capital Management’s portfolio.
Other Hedge Funds, Including , Alambic Investment Management added Q to its portfolio by purchasing 5,250 company shares during the most recent quarter which is valued at $402,938. Quintiles Transnational Holdings Inc makes up approx 0.09% of Alambic Investment Management’s portfolio.Td Asset Management Inc boosted its stake in Q in the latest quarter, The investment management firm added 600 additional shares and now holds a total of 6,212 shares of Quintiles Transnational Holdings Inc which is valued at $483,169.Gsa Capital Partners Llp reduced its stake in Q by selling 3,862 shares or 6.8% in the most recent quarter. The Hedge Fund company now holds 52,955 shares of Q which is valued at $4,118,840. Quintiles Transnational Holdings Inc makes up approx 0.21% of Gsa Capital Partners Llp’s portfolio.Creative Planning boosted its stake in Q in the latest quarter, The investment management firm added 382 additional shares and now holds a total of 2,540 shares of Quintiles Transnational Holdings Inc which is valued at $180,492.
Quintiles Transnational Holdings Inc opened for trading at $76.4 and hit $76.71 on the upside on Monday, eventually ending the session at $76.51, with a gain of 0.14% or 0.11 points. The heightened volatility saw the trading volume jump to 6,13,148 shares. Company has a market cap of $9,065 M.
On the company’s financial health, Quintiles Transnational Holdings Inc reported $0.93 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.90. The company had revenue of $1167.10 million for the quarter, compared to analysts expectations of $1150.61 million. The company’s revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.78 EPS.
Many Wall Street Analysts have commented on Quintiles Transnational Holdings Inc. Quintiles Transnational Holdings Inc was Upgraded by Avondale to ” Mkt Outperform” on Jul 12, 2016. Quintiles Transnational Holdings Inc was Downgraded by Wells Fargo to ” Market Perform” on May 12, 2016.
Quintiles Transnational Holdings Inc. is a biopharmaceutical services company. The Company is a provider of biopharmaceutical development services and commercial outsourcing services. The Company is engaged in the development and commercialization of pharmaceutical therapies. It also offers therapeutic scientific and analytical services to its biopharmaceutical and other healthcare customers. The Company offers its services through two segments: Product Development and Integrated Healthcare Services. Its product development segment is a contract research organization (CRO) and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. Its Integrated Healthcare Services segment provides services including commercial services such as contract pharmaceutical sales forces and healthcare business services such as phase research market access and consulting and health information analytics and technology consulting.